Search results
Experimental gene therapy restores some vision in patients with inherited blindness
CNN.com· 15 hours agoCook was born with an inherited retinal disorder that causes blindness, a rare type of eye disorder...
Taysha Gene Therapies Inc (TSHA) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 23 hours agoAs a result of the transaction, Manning Paul B now holds 16,466,667 shares, worth roughly $42.32 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating ...
Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park
CBS 47 Fresno· 16 hours agoIt is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and gene therapies (CGTs ...
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 13 hours agoOn CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on...
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 4 days agoRather than replacing or repairing a defective gene (as other gene therapies in development seek to do), modifier gene therapy ...
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo Finance· 5 days agoTaysha Gene Therapies (TSHA) doesn't possess the right combination of the two key ingredients for a...
AstraZeneca ups stake in Cellectis in latest cell therapy bet
BioPharma Dive via Yahoo Finance· 18 hours agoThe British drugmaker, which has made genetic medicine a larger priority of late, added $140 million...
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 3 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Think You Need A Good Stock? Look At This Taysha Gene Therapies Inc
Stocks Register· 6 days agoThe beta value is 0.32, while the average true range (ATR) is currently pointing at 0.25. Coming back to Taysha Gene Therapies Inc (NASDAQ:TSHA), we note
Study: Women can safely use hormone replacement therapy during menopause
UPI· 5 days agoHormone replacement therapy can safely ease middle-aged women's symptoms during early menopause,...